Cumberland Pharmaceuticals (CPIX) Cash from Operations Growth (3y) (2013 - 2026)
Cumberland Pharmaceuticals (CPIX) Cash from Operations Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | 8.25% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 52.97% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 5.90% |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 43.42% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -10.08% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | -8.76% |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | 65.60% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Cumberland Pharmaceuticals | 116.56 Mn | 112.69 Mn | - | -39.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -39.97% |
| Mar 31, 2026 | 31.48% |
| Dec 31, 2025 | -90.60% |
| Sep 30, 2025 | -58.59% |
| Jun 30, 2025 | -28.73% |
| Mar 31, 2025 | 203.31% |
| Dec 31, 2024 | -17.97% |
| Sep 30, 2024 | 31.97% |
| Jun 30, 2024 | -32.33% |
| Mar 31, 2024 | -47.31% |
| Dec 31, 2023 | 6.80% |
| Sep 30, 2023 | -17.83% |
| Jun 30, 2023 | 53.62% |
| Mar 31, 2023 | -53.21% |
| Dec 31, 2022 | 61.92% |
| Sep 30, 2022 | 53.10% |
| Jun 30, 2022 | 7.99% |
| Mar 31, 2022 | 26.93% |
| Dec 31, 2021 | 85.88% |
| Sep 30, 2021 | 0.97% |